MNG581
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | TCGA-P3-A5Q6-01A-11R-A28V-07 | — | — | 0.825 |
| 2 | TCGA-UY-A78M-01A-21R-A352-07 | — | — | 0.804 |
| 3 | MNG1117 | — | — | 0.799 |
| 4 | SRR1516100 | — | — | 0.778 |
| 5 | DRR168602 | — | — | 0.767 |
| 6 | R26 | — | — | 0.761 |
| 7 | MNG952 | — | — | 0.753 |
| 8 | AUR-AE6X-TTM1-A-1-1-R-A742-41 | — | E | 0.745 |
| 9 | R308 | — | — | 0.742 |
| 10 | MNG754 | — | — | 0.740 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 31 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| MYC_TARGETS_V2 | 0.425 | Idelalisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.397 | Remibrutinib | — uncovered |
| ANGIOGENESIS | 0.395 | Remibrutinib | — uncovered |
| REACTIVE_OXYGEN_SPECIES_PATHWAY | 0.315 | Inavolisib | — uncovered |
| COAGULATION | 0.313 | Binimetinib | — uncovered |
| MYC_TARGETS_V1 | 0.294 | Inavolisib | — uncovered |
| ADIPOGENESIS | 0.276 | Inavolisib | — uncovered |
| HYPOXIA | 0.263 | Idelalisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.247 | Cobimetinib | — uncovered |
| GLYCOLYSIS | 0.240 | Inavolisib | — uncovered |
| CHOLESTEROL_HOMEOSTASIS | 0.234 | Remibrutinib | — uncovered |
| UV_RESPONSE_UP | 0.217 | Idelalisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.184 | Inavolisib | — uncovered |
| DNA_REPAIR | 0.179 | Idelalisib | — uncovered |
| MYOGENESIS | 0.156 | Inavolisib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.144 | Inavolisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.140 | Idelalisib | — uncovered |
| ESTROGEN_RESPONSE_LATE | 0.129 | Idelalisib | — uncovered |
| MTORC1_SIGNALING | 0.122 | Inavolisib | — uncovered |
| NOTCH_SIGNALING | 0.118 | Inavolisib | — uncovered |